Literature DB >> 23702196

Timing of intra-lesion shaving for surgical treatment of chronic tophus.

Su-Shin Lee1, Meng-Chum Chen, Yun-Hui Chou, Sin-Daw Lin, Chung-Sheng Lai, Ying-Cheng Chen.   

Abstract

OBJECTIVES: Gouty arthritis results from the deposition of monosodium urate crystals in synovial spaces. The literature shows that a tophus may require surgical treatment to improve cosmesis or function, to alleviate pain, to eradicate sinus drainage or to remove large urate deposits. However, forceful curettage to remove tophus particles embedded in the thin attenuated skin flap may compromise blood circulation and cause other complications. This series presents the experience of the authors in performing intra-lesion shaving during the surgical treatment of tophus patients.
METHODS: This study analysed 147 surgical procedures performed in 108 patients with chronic tophus at a single hospital during November 2000 to July 2010. All patients underwent a soft-tissue shaver-assisted intra-lesion excavating technique developed by the authors. Bimanual palpation of the skin was performed to avoid trauma to the skin envelope. The shaving technique proved to be a simple and efficient method of reducing the total urate burden in the body.
RESULTS: Compared to conventional surgical treatment, the shaver technique is a safer and more effective option for treating tophus lesions. In this series, wound cultures were positive in 18.4% of operations. Patients with positive wound cultures and chronic renal impairment had significantly longer hospital stays compared to patients with negative wound cultures and patients without chronic renal impairment (P=0.0019 and P=0.0045, respectively); patients with C-reactive protein (CRP)<5 mg l(-1) and white blood cell (WBC) count<10,000 μl(-1) had significantly shorter hospital stays compared to patients with CRP>5 mg l(-1) and WBC>10,000 μl(-1) (P=0.0002 and 0.006, respectively). The upper extremities group and the upper-lower extremities group had significantly shorter hospital stays compared to the lower extremities group (P=0.001 and P=0.0014, respectively).
CONCLUSIONS: Medical treatment to control hyperuricaemia is important for reducing the risk of an acute attack of tophus formation. However, the data in this series show that surgery should be performed before the skin becomes ulcerated and before the tophus mass becomes infected. The proposed shaver technique markedly reduces tophus of the extremities with minimal surgical complications.
Copyright © 2013 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gout; Hyperuricaemia; Shaver; Surgery; Tophus

Mesh:

Substances:

Year:  2013        PMID: 23702196     DOI: 10.1016/j.bjps.2013.03.041

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

Review 1.  Beyond Medical Treatment: Surgical Treatment of Gout.

Authors:  Jonathan Carcione; Shari Bodofsky; Brian LaMoreaux; Naomi Schlesinger
Journal:  Curr Rheumatol Rep       Date:  2020-11-24       Impact factor: 4.592

2.  Evolution of gout: "malignant" change over time?

Authors:  Sterling Ellis Eide; Yiu Ming Khor; Ju Ee Seet; David Soon Yiew Sia
Journal:  J Radiol Case Rep       Date:  2015-10-31

3.  En Masse Excision and Curettage for Periarticular Gouty Tophi of the Hands.

Authors:  Matthew Doscher; Bryan G Beutel; Andrew Lovy; Brandon Alba; Charles Melone
Journal:  Eplasty       Date:  2022-07-12

4.  Operative management of gouty tophi in the region of the olecranon: a case series.

Authors:  Joshua D Kirschenbaum; Ruby G Patel; Matthew R Boylan; Mandeep S Virk
Journal:  JSES Int       Date:  2022-02-23

5.  Surgical Treatment of Hand and Foot Gout Stone and Influence Factors on Prognosis.

Authors:  Xudong Qiu; Bo Zhao; Xingxu Du; Shuo Jin; Weiyan Zhao
Journal:  Comput Math Methods Med       Date:  2022-09-26       Impact factor: 2.809

6.  Ulcerated Tophaceous Gout.

Authors:  Hovra Zahoor; Ronak Patel; Jessica El-Bahri
Journal:  Cureus       Date:  2022-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.